Preliminary ICBPS II Programme　初步会议议程

Sunday, Dec. 7,2008

10:00 am -- 06:00 pm

Registration

06:30 pm -- 08:00 pm

Welcome Reception

Monday, Dec.8,2008

08:30 am -- 09:00 am

Opening Ceremony

09:00 am -- 12:00 am

Session I ICBPS-2 Overview and General Vaccine Development

09:00 am -- 09:40 am

Vaccine Standardization and Evaluation: WHO Perspective

Dr.Ivana Knezevic,Scientist, FCH/IVB/QSS, World Health Organization

09:40am -- 10:20 am

The US FDA Two Animal Rule

Dr. Virginia Johnson, Vice President Regulatory Affairs, Emergent BioSolutions, USA

10:20 am -- 10:35 am

Break

10:35 am -- 11:15 am

Countering The Misuse of Biological Agents: Indonesian Perceptions on Biosafety and Biosecurity

Dr. Isroil Samihardjo, Centre for Defence Science and Technological Research and Member Indonesian National Authority for Prohibition of WMD

11:15 am -- 11:55 am

National Important S&T Project of Infectious Disease Vaccine Evaluation

Prof. Wang Junzhi,Deputy Director, National Institute for the Control of Pharmaceutical and Biological Products(NICPBP),China

12:00 am -- 01:30 pm

Lunch

01:30 pm -- 05:00 pm

Session II Quality Contral and Regulation

01:30 pm -- 02:10 pm

Scientific and Regulatory Issues Concerning Vaccines against Emerging Infections

Dr. Elwyn Griffiths,Associate Director General,Biologics and Genetic Therapies Directorate,Health Canada

02:10 pm -- 02:50 pm

EU Regulatory Affairs on Medicinal Product Registration

Prof. Emeritus Atilla Hincal, Hacettepe University, Ankara, Turkey, Co-founder CRO IDE

02:50 pm -- 03:05 pm

Break

03:05 pm -- 03:45 pm

Quality Control Study of Pandemic Influenza Vaccine

Prof.Changgui Li, Division of Viral vaccine, NICPBP,China

03:45 pm -- 04:25 pm

Pre-clinical and Clinical Evaluatiuon of New Vaccine

Center for Drug Evalution,SFDA,China

04:25 pm -- 05:05 pm

IP Strategies for Chinese Pharmaceutical and Biotechnology Companies

Philip Zhang, J.D., Ph.D., Attorney at Law,Special Counsel, Cooley Godward Kronish LLP,USA

Thuesday ,December 9,2008

09:00 am -- 12:00 am

Session III Vaccine R&D

09:00 am -- 09:40 am

Studies on HIV Preventive Vaccines in China

Prof.Youchun Wang,Department of Cell Biology, NICPBP,China

09:40 am -- 10:20 am

Construction and Quality Control of Recombinant Vaccine of Human Helicobacter Pylori

Prof. Quanming Zou,The Third Military Medical University,China

10:20 am -- 10:50 am

Break and Poster Show

All authors of posters are suggested near your poster

10:50 am -- 11:30 am

Study and application of Japanese encephahalitis Vaccine

Prof. Dong Guanmu,NICPBP,China

11:30 am -- 12:10 am

Control of Infectious Diseases and R&D of Vaccines

Mr. Yin Weidong, Manager General,Sinovac Biotech Co.,Ltd

12:10 am -- 01:30 pm

Lunch

01:30 pm -- 05:00 pm

Session III （CONTINUE）

Chair: Prof.Li Fengxiang,NICPBP，China

Co-chair: Dr. Xiaomi Tong,Senior Director, Regulatory Affairs, Emergent Biosolutions, Rockville, Maryland USA

01:30 pm -- 02:10 pm

Construction of recombinant modified vaccinia virus with Ag85a and ESAT-6 gene and examination of their immunogenicity in mice

Prof. Lou Jue-ren,The Second Laboratory, Shanghai Institute of Biological Products,CNBG

02:10 pm -- 02:50 pm

A study on the cellular and humoral immune responses vaccinated by different kinds of recombinant hepatitis B vaccines and HBsAg

Hu Zhongyu. ,National Institute for the Control of Pharmaceutical and Biological Products

02:50 pm -- 03:05 pm

Break

03:05 pm -- 03:45 pm

EV71 Vaccine

To be Confiemed CNBG

03:45 pm -- 04:25 pm

Pneumococcal polyvalent polysaccharide and conjugate vaccine

Prof.Ye Qiang, NICPBP,China

04:25 pm -- 05:05 pm

Battelle Memorial Institute’s Health and Life Sciences Bio-Initiative Program

Dr. Kevin Xie, Battelle Memorial Institute, Columbus, Ohio USA

05:40 pm

Depart Hotel Crowne Plaza for Symposium Dinner- a very special venue and during the dinner, Chinese culture will be highlighted.

Wednesday, Dec.10,2008

09:00 am -- 12:00 am

Session IV Vaccine Tedchnology Development

09:00 am -- 09:40 am

large-scale cell-culture technicque

Prof.Yang Xiaoming, Wuhan Institute of Biological Products,CNBG

09:40 am -- 10:20 am

Clinical development of a seasonal influenza vaccine by intradermal micro-injection

Dr.Victor Carey,Medical Director,sanofi pasteur,Australia

10:20 am -- 10:35 am

Break

10:35 am -- 11:15 am

Vector Borne Diseases in the Asian Part of Russia, A Short Review

Prof. Sergey Netesov, Vice Rector Research, Novosibirsk State University, Russia

11:15 am -- 11:55 am

Modulation of Liver Fibrosis Development Following Supplementation of Aloe Arborescens: In Vivo Study

Dr. Mohamed ElZarka, Spiros Foundation, Cairo, Egypt

12:00 am -- 01:00 pm

Lunch

01:00 pm -- 04:30 pm

Buses leave for Tour to Industry(Two destination for selection)

A: Beijing Tiantan Biological Products Co.Ltd

B:Zhongguancun Life Science Park

(Please you decided your selection at the registration desk)

Thursday, Dec.11,2008

09:00 am -- 12:00 am

Session V Biopharm Development

09:00 am -- 09:35 am

Bacteriophages Against Methinillin-Resistant S.aureus(MRSA)

Dr. Mzia KUTATELADZE,G.Eliava Institute of Bacteriophages, Microbiology and Virology,Republic of Georgia

09:35 am -- 10:10 am

Bacteriophage – New applications to the challenge of antibiotic resistant and emerging bacteria.

Dr. David Trudil, Battelle Memorial Institute,USA

10:10 am -- 10:25 am

Break

10:25 am -- 11:00 am

Safety Issues in Biosimilars/Follow-on Biopharmaceuticals

Prof. Filiz Hincal, Hacettepe University, Ankara, Turkey

11:00 am -- 11:35 am

Progress in the research of DNA vaccine delivery system

Luo Dan,Wuhan Institute of Biological Products,CNBG

11:40 am -- 12:00 am

Closing Ceremony

12:00 am -- 01:00 pm

Lunch

01:00 pm -- 05:30 pm

Buses leave for Cultural Tour (To Great Wall )

Only available for International attendees